The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

David Spigel, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.

April 14, 2015

CancerTREATMENT NGS+ in the Clinic

Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.

September 2, 2015

Changing the Way Takeda Oncology Develops Cancer Medicines

Dixie-Lee Esseltine, MD and George Mulligan, PhD offer insight on the impact of ixazomib on Takeda Oncology’s approach to multiple myeloma care and its approach to other cancer types.